Skip to main content

Table 1 Demographics of IS and IR groups

From: Hyperinsulinemia improves ischemic LV function in insulin resistant subjects

Parameters Insulin Sensitive (IS) Insulin Resistant (IR) P
Age 64 (8) 64.2 (8) ns
Male, n (%) 11 (92) 10 (83) ns
Medication, n (%)    
β-Blocker 11 (92) 11 (92) ns
Nitrate 9 (75) 6 (50) ns
Calcium Channel Blocker 2 (17) 3 (25) ns
Statin 12 (100) 11 (92) ns
Ejection Fraction, % 62.2 (4) 63.3 (6) ns
Coronary Disease, n (%)    
LAD stenosis 6 (50) 10 (83) ns
LCx stenosis 4 (33) 3 (25) ns
RCA stenosis 5 (42) 5 (42) ns
Single vessel CAD 10 (83) 8 (67) ns
Two vessel CAD 1 (8) 2 (17) ns
Three vessel CAD 1 (8) 2 (17) ns
Weight (Kg) 82 (15) 97.5 (20) 0.04
BSA (m2) 1.96 (0.2) 2.1 (0.2) ns
M Value (mg/kg/min) 5.7 (1.3) 2.2 (0.7) < 0.0001
Diabetes* n (%) 3 (25) 6 (50) ns
   Diet controlled 3 (25) 2 (17) ns
   Metformin 0 3 (25) ns
   Metformin and sulphonyl urea 0 1 (25) ns
  1. BSA = body surface area. * = subjects with a clinical diagnosis of type 2 diabetes receiving oral hypoglycemic agents. Ns = not significant